Old Web
English
Sign In
Acemap
>
authorDetail
>
Mai Watanabe
Mai Watanabe
Taisho Pharmaceutical Co.
Cmax
Pharmacology
Oral administration
Prodrug
Pharmacokinetics
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of the safety, tolerability and pharmacokinetic profiles of TP0473292 (TS-161), a prodrug of a novel orthosteric mGlu2/3 receptor antagonist TP0178894, in healthy subjects and its antidepressant-like effects in rodents.
2021
The International Journal of Neuropsychopharmacology
Mai Watanabe
Brian Marcy
Ayano Hiroki
Hirotaka Watase
Kohnosuke Kinoshita
Michihiko Iijima
Toshiyuki Marumo
Carlos A. Zarate
Shigeyuki Chaki
Show All
Source
Cite
Save
Citations (0)
Safety and Pharmacokinetic Profiles of MGS0274 Besylate (TS-134), a Novel Metabotropic Glutamate 2/3 Receptor Agonist Prodrug, in Healthy Subjects.
2020
British Journal of Clinical Pharmacology
Mai Watanabe
Brian Marcy
Kohnosuke Kinoshita
Misako Fukasawa
Hirohiko Hikichi
Shigeyuki Chaki
Shigeru Okuyama
Hakop Gevorkyan
Shigeru Yoshida
Show All
Source
Cite
Save
Citations (2)
1